Study of Live Attenuated ChimeriVax™-Japanese Encephalitis Vaccine

Clinical trial NCT00981630 · COMPLETED

Trial details

NCT number: NCT00981630
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Japanese Encephalitis

Start date: 2004-11-01
Primary completion: 2006-02-01
Enrollment: 128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.